NBC Securities’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15
Closed -$17.6K 2743
2025
Q4
$17.6K Hold
15
﹤0.01% 1826
2025
Q3
$22.5K Buy
+15
New +$418 ﹤0.01% 1692

Other funds holding MRNA

NBC Securities's MRNA Position: Q2 2026 in Review

NBC Securities reduced its Moderna (MRNA) stake by 43% in Q2 2026, selling an estimated $11.1K and leaving 279 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

NBC Securities first reported a position in MRNA in Q3 2023 and has held it in 11 quarters since. The position peaked at $122K in Q1 2024. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • NBC Securities held 279 shares of Moderna worth $19.5K as of Q2 2026.
  • NBC Securities sold 214 Moderna shares in Q2 2026, an estimated $11.1K.
  • Moderna made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1663 holding.
  • NBC Securities first reported a position in Moderna in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Moderna position peaked at $122K in Q1 2024.
  • 184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.